Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-107826
Filing Date
2024-09-18
Accepted
2024-09-18 16:36:53
Documents
2
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1557
2 EX-24.1 aktx-ex24_1.htm EX-24.1 15437
  Complete submission text file 0000950170-24-107826.txt   18579
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 33 HAYDEN AVE LEXINGTON MA 02421
Business Address
Bazemore Robert B (Reporting) CIK: 0001620152 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36288 | Film No.: 241308004